DGAP-News: Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013

DGAP-News: Novavax to Report Third Quarter 2013 Financial Results on November 
7, 2013

Novavax, Inc. 

30.10.2013 21:58

ROCKVILLE, Md., 2013-10-30 21:57 CET (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call
and live webcast to report its third quarter 2013 financial results on
Thursday, November 7, 2013, at 4:30 p.m. ET. 

The dial-in number for the conference call is 1 (877) 212-6076 (U.S. or Canada)
or 1 (707) 287-9331 (international). A webcast of the conference call can also
be accessed via a link on the home page of the Novavax website (novavax.com) or
through the 'Investor Info'/'Events' tab on the Novavax website. 

A replay of the conference call will be available from 7:30 pm on November 7,
2013 until midnight December 6, 2013. To access the replay by telephone, dial 1
(855) 859-2056 (domestic) or 1 (404) 537-3406 (international) and use passcode
93831495. The replay will also be available as a webcast and can be found on
the 'Investor Info'/'Events' on the Novavax website. 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine candidates to
efficiently and effectively respond to both known and newly emergent diseases.
Novavax is involved in several international partnerships, including
collaborations with Cadila Pharmaceuticals of India, LG Life Sciences of Korea
and PATH, and recently acquired Isconova AB, a leading vaccine adjuvant company
located in Sweden. Together, Novavax' network supports its global
commercialization strategy to create real and lasting change in the
biopharmaceutical and vaccinology fields. Additional information about Novavax
is available on the company's website, novavax.com. 

         CONTACT: Barclay Phillips
         SVP, Chief Financial Officer and Treasurer
         Novavax, Inc.
News Source: NASDAQ OMX

30.10.2013 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

Language:     English
Company:      Novavax, Inc.
              United States
ISIN:         US6700021040
End of Announcement                             DGAP News-Service
Press spacebar to pause and continue. Press esc to stop.